X0306 4 2015-07-27 0 0000891293 CTI BIOPHARMA CORP ctic 0001474462 SEELEY BRUCE J. 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 0 1 0 0 EVP, Chief Commercial Officer Common Stock 2015-07-27 4 A 0 300000 0 A 300000 D Performance Rights 0 2015-07-27 4 A 0 406483 0 A 2016-12-31 Common Stock 406483 406483 D Restricted stock award will vest in three installments with one-third of the award on each of (i) July 27, 2016; (ii) July 27, 2017; and (iii) July 27, 2018, subject to the officer's continued service with the Company. This transaction represents a grant of performance-based restricted stock units pursuant to CTIC's long-term incentive program. The reporting person has been granted an award that is payable in shares of CTIC common stock upon the achievement of certain performance goals on or before December 31, 2016. Should such a goal be timely achieved, the number of shares payable will be determined by multiplying the payout percentage that has been assigned by CTIC to that goal multiplied by the number of shares of CTIC common stock issued and outstanding at the time that particular goal has been achieved. One such performance goal is the attainment by CTIC of a specified level of market capitalization. The units reported above reflect the 0.225% payout percentage that has been assigned by CTIC to this market capitalization goal for purposes of the reporting person's award multiplied by the number of shares of CTIC common stock issued and outstanding as of July 27, 2015. By: Louis A. Bianco, Attorney-in-fact For: Bruce J. Seeley 2015-07-29